Press
Resources

About
Myeloma
- Q&A
- Treatments
- Books
- News
- Research Projects
Testimonials
Donate
Press
Resources
Myeloma BioBank
Events
Contact

About
Myeloma
- Q&A
- Treatments
- Books
- News
- Research Projects
Testimonials
Donate
Press
Resources
Myeloma BioBank
Events
Contact

Myeloma Today – COVID-19 Vaccines in MM Patients

Responses to mRNA COVID-19 Vaccines in MM Patients

(310) 623-1210 contactus@imbcr.org (310) 623-1120 9201 Sunset Blvd. Suite 300
West Hollywood, CA 90069

Myeloma
Research Team
Our Impact
About IMBCR

Events
Donate
Contact
Careers

Copyright © 2024 IMBCR, Inc. All rights reserved.

Events
Donate
Contact
Careers

Contact form

[gravityform id="3" title="false" description="false"]

Contact Us

(000) 000-0000

Previous Post

Benefits of MRD Testing for the Treatment of Patients With Multiple Myeloma
Category: Press Releases
At the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Joseph Mikhael, MD, MEd, FRCPC, FACP, Translational Genomics Research Institute, City of Hope Cancer Center, Phoenix, Arizona, argued in favor of minimal residual disease (MRD) testing for patients with multiple myeloma, in both a

Next Post

BuzzFeed News – Colin Powel Has Died Of COVID
Category: Press Releases
Colin Powell: The First Black Secretary Of State, Has Died Of COVID